- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07451080
Impact of Anterior Clinoid Process Pneumatization on Optic Canal and Retinal Nerve Fiber Layer
Evaluation of the Effects of Anterior Clinoid Process Pneumatization on Optic Canal Morphometry and Retinal Nerve Fiber Layer Thickness Using Computed Tomography and Optical Coherence Tomography: A Retrospective Cohort Study
This retrospective cohort study aims to evaluate the potential effects of anterior clinoid process (ACP) pneumatization on optic canal morphometry and retinal nerve fiber layer (RNFL) thickness. ACP pneumatization is an anatomical variation that may alter the morphology of the optic canal and potentially influence the optic nerve.
Patients aged 18-65 years with available head and neck computed tomography (CT) imaging and optical coherence tomography (OCT) examinations between August 2018 and July 2025 will be retrospectively reviewed. Optic canal length and diameter will be measured using CT images, and RNFL thickness parameters will be obtained from OCT records. Measurements will be compared between patients with and without ACP pneumatization.
Study Overview
Status
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Elâzığ, Turkey (Türkiye)
- Fethi Sekin City Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Adults aged 18 to 65 years.
- Availability of head and neck computed tomography (CT) imaging in the hospital archive.
- Availability of optical coherence tomography (OCT) examination records in the hospital archive.
- CT and OCT examinations performed between August 2018 and July 2025.
Exclusion Criteria:
- Age <18 years or >65 years. History or evidence of diabetes mellitus. History or evidence of hypertension. Glaucoma. Any condition or diagnosis that may cause optic nerve pathology (e.g., optic neuritis, compressive optic neuropathy, optic atrophy, demyelinating disease affecting the optic nerve).
Inadequate image quality or incomplete CT/OCT data preventing reliable measurements.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
ACP Pneumatization Present
Participants with radiologically confirmed anterior clinoid process (ACP) pneumatization identified on computed tomography imaging.
|
|
ACP Pneumatization Absent
Participants without radiological evidence of anterior clinoid process (ACP) pneumatization on computed tomography imaging.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Optic Canal Length
Time Frame: Baseline (retrospective review of CT images obtained between August 2018 and July 2025)
|
Optic canal length measured on computed tomography (CT) images.
|
Baseline (retrospective review of CT images obtained between August 2018 and July 2025)
|
|
Optic Canal Mean Diameter
Time Frame: Baseline (retrospective review of CT images obtained between August 2018 and July 2025)
|
Optic canal mean diameter measured on computed tomography (CT) images.
|
Baseline (retrospective review of CT images obtained between August 2018 and July 2025)
|
|
Retinal Nerve Fiber Layer (RNFL) Thickness
Time Frame: Baseline (retrospective review of OCT images obtained between August 2018 and July 2025)
|
Peripapillary retinal nerve fiber layer thickness measured by optical coherence tomography (OCT).
|
Baseline (retrospective review of OCT images obtained between August 2018 and July 2025)
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- EFSH-NIEC-2025-13-23
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.